Cargando…

The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma

PURPOSE: The 7th TNM classification summarizes renal cell carcinoma (RCC) with perirenal (PFI) and/or sinus fat invasion (SFI) as well as hilar vein involvement (RVI) as pT3a tumors. In this study, we aimed to determine the prognostic value of fat invasion (FI) in the different compartments and RVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Stühler, Viktoria, Rausch, Steffen, Kroll, Katharina, Scharpf, Marcus, Stenzl, Arnulf, Bedke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510928/
https://www.ncbi.nlm.nih.gov/pubmed/33638011
http://dx.doi.org/10.1007/s00345-021-03638-0
_version_ 1784582677869887488
author Stühler, Viktoria
Rausch, Steffen
Kroll, Katharina
Scharpf, Marcus
Stenzl, Arnulf
Bedke, Jens
author_facet Stühler, Viktoria
Rausch, Steffen
Kroll, Katharina
Scharpf, Marcus
Stenzl, Arnulf
Bedke, Jens
author_sort Stühler, Viktoria
collection PubMed
description PURPOSE: The 7th TNM classification summarizes renal cell carcinoma (RCC) with perirenal (PFI) and/or sinus fat invasion (SFI) as well as hilar vein involvement (RVI) as pT3a tumors. In this study, we aimed to determine the prognostic value of fat invasion (FI) in the different compartments and RVI for medium-term cancer-specific-survival (CSS) in pT3a RCC. MATERIALS AND METHODS: Patients with pT3a RCC were identified using an institutional database. All original pathological reports were reclassified according to the 7th TNM edition. The prognostic value of FI as well as divided into PFI, SFI, combined PFI + SFI, and RVI for CSS was assessed using univariate and multivariate Cox-regression analysis. Survival was estimated using the Kaplan–Meier method. RESULTS: Median follow-up in 184 pT3a tumors was 38 months. FI was detectable in 153 patients (32.7% PFI, 45.1% SFI, 22.2% PFI + SFI), 31 patients showed RVI alone. Combined PFI + SFI increased the risk of cancer-related death compared to PFI (HR 3.11, p < 0.01), SFI (HR 1.84, p = 0.023) or sole RVI (HR 2.12, p = 0.025). In multivariate analysis, a combined PFI + SFI vs. PFI or SFI as the only compartment involved was confirmed as independent prognostic factor (HR 1.83, p = 0.029). Patients with FI and simultaneous RVI had significantly shorter CSS (HR 2.63, p < 0.01). In an unweighted model, the difference between patients with combined PFI + SFI and RVI and those with PFI alone was highest (HR 4.01, p = 0.029). CONCLUSIONS: These results underline the subdivision of pT3a RCC depending on the location of FI and RVI for patient stratification.
format Online
Article
Text
id pubmed-8510928
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-85109282021-10-27 The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma Stühler, Viktoria Rausch, Steffen Kroll, Katharina Scharpf, Marcus Stenzl, Arnulf Bedke, Jens World J Urol Original Article PURPOSE: The 7th TNM classification summarizes renal cell carcinoma (RCC) with perirenal (PFI) and/or sinus fat invasion (SFI) as well as hilar vein involvement (RVI) as pT3a tumors. In this study, we aimed to determine the prognostic value of fat invasion (FI) in the different compartments and RVI for medium-term cancer-specific-survival (CSS) in pT3a RCC. MATERIALS AND METHODS: Patients with pT3a RCC were identified using an institutional database. All original pathological reports were reclassified according to the 7th TNM edition. The prognostic value of FI as well as divided into PFI, SFI, combined PFI + SFI, and RVI for CSS was assessed using univariate and multivariate Cox-regression analysis. Survival was estimated using the Kaplan–Meier method. RESULTS: Median follow-up in 184 pT3a tumors was 38 months. FI was detectable in 153 patients (32.7% PFI, 45.1% SFI, 22.2% PFI + SFI), 31 patients showed RVI alone. Combined PFI + SFI increased the risk of cancer-related death compared to PFI (HR 3.11, p < 0.01), SFI (HR 1.84, p = 0.023) or sole RVI (HR 2.12, p = 0.025). In multivariate analysis, a combined PFI + SFI vs. PFI or SFI as the only compartment involved was confirmed as independent prognostic factor (HR 1.83, p = 0.029). Patients with FI and simultaneous RVI had significantly shorter CSS (HR 2.63, p < 0.01). In an unweighted model, the difference between patients with combined PFI + SFI and RVI and those with PFI alone was highest (HR 4.01, p = 0.029). CONCLUSIONS: These results underline the subdivision of pT3a RCC depending on the location of FI and RVI for patient stratification. Springer Berlin Heidelberg 2021-02-27 2021 /pmc/articles/PMC8510928/ /pubmed/33638011 http://dx.doi.org/10.1007/s00345-021-03638-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Stühler, Viktoria
Rausch, Steffen
Kroll, Katharina
Scharpf, Marcus
Stenzl, Arnulf
Bedke, Jens
The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma
title The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma
title_full The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma
title_fullStr The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma
title_full_unstemmed The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma
title_short The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma
title_sort prognostic value of fat invasion and tumor expansion in the hilar veins in pt3a renal cell carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510928/
https://www.ncbi.nlm.nih.gov/pubmed/33638011
http://dx.doi.org/10.1007/s00345-021-03638-0
work_keys_str_mv AT stuhlerviktoria theprognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT rauschsteffen theprognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT krollkatharina theprognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT scharpfmarcus theprognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT stenzlarnulf theprognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT bedkejens theprognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT stuhlerviktoria prognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT rauschsteffen prognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT krollkatharina prognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT scharpfmarcus prognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT stenzlarnulf prognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma
AT bedkejens prognosticvalueoffatinvasionandtumorexpansioninthehilarveinsinpt3arenalcellcarcinoma